We are live on ! Find out more
AIA

AIMZ Investment Advisors Portfolio holdings

AUM $324M
1-Year Est. Return 18.77%
This Fund
S&P 500
This Quarter Est. Return
+11.3%
1 Year Est. Return
+18.77%
3 Year Est. Return
+63.89%
5 Year Est. Return
+85.69%
10 Year Est. Return
+323.28%
AUM
$257M
AUM Growth
+$35.3M
Cap. Flow
+$12.5M
Cap. Flow %
4.87%
Top 10 Hldgs %
33.45%
Holding
121
New
8
Increased
55
Reduced
24
Closed
2

Top Sells

Rank Stock Value
1
PLTR icon
Palantir
PLTR
+$215K
2
ALL icon
Allstate
ALL
+$204K
3
DELL icon
Dell
DELL
+$153K
4
IBM icon
IBM
IBM
+$128K
5
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$77.3K

Sector Composition

Rank Sector Weight
1 Technology 32.7%
2 Healthcare 27.96%
3 Industrials 12.86%
4 Financials 7.54%
5 Consumer Discretionary 5.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.95T
$18.3M 7.1%
102,793
+121
+0.1% +$19.1K
MSFT icon
2
Microsoft
MSFT
$2.89T
$12.2M 4.75%
36,266
+271
+0.8% +$87.9K
QCOM icon
3
Qualcomm
QCOM
$179B
$10.1M 3.91%
54,985
+522
+1% +$83.6K
INFY icon
4
Infosys
INFY
$47.4B
$8.47M 3.3%
334,652
+1,757
+0.5% +$40.8K
REGN icon
5
Regeneron Pharmaceuticals
REGN
$69.9B
$7.21M 2.81%
11,424
+125
+1% +$76.9K
TROW icon
6
T. Rowe Price
TROW
$25.5B
$7.05M 2.75%
35,871
+383
+1% +$77.8K
NTAP icon
7
NetApp
NTAP
$33.3B
$6.16M 2.4%
66,986
+709
+1% +$63.9K
EXPD icon
8
Expeditors International
EXPD
$22.4B
$5.79M 2.25%
43,114
+520
+1% +$65.1K
META icon
9
Meta Platforms (Facebook)
META
$1.51T
$5.45M 2.12%
16,215
-39
-0.2% -$12.9K
VRTX icon
10
Vertex Pharmaceuticals
VRTX
$122B
$5.29M 2.06%
24,080
+400
+2% +$77.8K
GILD icon
11
Gilead Sciences
GILD
$162B
$5.08M 1.98%
70,031
+1,262
+2% +$86.9K
CHRW icon
12
C.H. Robinson
CHRW
$20.6B
$5.08M 1.98%
47,214
+804
+2% +$78.1K
CSCO icon
13
Cisco
CSCO
$452B
$4.85M 1.89%
76,516
-544
-0.7% -$31.1K
INCY icon
14
Incyte
INCY
$23.7B
$4.37M 1.7%
59,532
+34,222
+135% +$2.31M
GSK icon
15
GSK
GSK
$104B
$4.27M 1.66%
77,447
+1,848
+2% +$96.1K
WBA
16
DELISTED
Walgreens Boots Alliance
WBA
$4.02M 1.57%
77,084
+1,763
+2% +$85.4K
ADBE icon
17
Adobe
ADBE
$94.5B
$3.85M 1.5%
6,790
-75
-1% -$46.9K
AZN icon
18
AstraZeneca
AZN
$263B
$3.8M 1.48%
32,648
+744
+2% +$87.5K
UNH icon
19
UnitedHealth
UNH
$379B
$3.75M 1.46%
7,474
-4
-0.1% -$1.81K
CTAS icon
20
Cintas
CTAS
$84.4B
$3.72M 1.45%
33,548
+800
+2% +$86.2K
LOW icon
21
Lowe's Companies
LOW
$119B
$3.65M 1.42%
14,140
+202
+1% +$48K
BRK.B icon
22
Berkshire Hathaway Class B
BRK.B
$1.07T
$3.58M 1.39%
11,964
BEN icon
23
Franklin Resources
BEN
$17.3B
$3.57M 1.39%
106,628
+1,916
+2% +$63.1K
PRLB icon
24
Protolabs
PRLB
$1.85B
$3.47M 1.35%
+67,528
New +$3.98M
AMGN icon
25
Amgen
AMGN
$203B
$3.45M 1.34%
15,354
+401
+3% +$84.6K

Similar funds

AIMZ Investment Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, AIMZ Investment Advisors held 121 positions worth $257M, up 16% from $222M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

AIMZ Investment Advisors deployed $12.5M of net new capital in Q4 2021, opening 8 new positions and adding to 55 existing holdings. Its largest new stake was Protolabs: 67,528 shares worth $3.47M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Dell, an estimated $153K trimmed.

  • AIMZ Investment Advisors's largest Q4 2021 buy was Protolabs: 67,528 shares worth $3.47M.
  • AIMZ Investment Advisors added most to Incyte in Q4 2021, an estimated $2.31M increase.
  • AIMZ Investment Advisors's biggest Q4 2021 reduction was Dell, cutting an estimated $153K.
  • AIMZ Investment Advisors fully exited Palantir in Q4 2021, selling an estimated $215K.
  • AIMZ Investment Advisors's ten largest holdings make up 33% of its $257M portfolio in Q4 2021.
  • AIMZ Investment Advisors opened 8 new positions and closed 2 in Q4 2021.
  • AIMZ Investment Advisors's portfolio value rose 16% quarter-over-quarter to $257M.

Based on AIMZ Investment Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.